Frank T. Watkins, Director at Shockwave Medical, Inc. (SWAV), sold 3,300 shares at $268.52 ($881K) on 2023-07-20, disclosed to the SEC on 2023-07-21.
Seasonal sale ($881k) by Director — this insider has traded SWAV in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $265.41 | 300 | $80K | 9.0% |
| 2 | $265.41 | 300 | $80K | 9.0% |
| 3 | $266.70 | 1,200 | $320K | 36.3% |
| 4 | $267.80 | 1,300 | $348K | 39.5% |
| 5 | $268.52 | 200 | $54K | 6.1% |
| Total | $267.01 avg | 3,300 |
| $881K |
| 100% |
| Filing → |
| SWAV | SELL | 2024-01-10 | $398K | — | Filing → |
| SWAV | SELL | 2023-11-21 | $926K | — | Filing → |
| SWAV | SELL | 2023-10-23 | $608K | — | Filing → |